Apr 24, 2020 - Eli Lilly (LLY) announces Q1 results. Pfizer (PFE) and Novartis (NVS) provide update on their studies/plans to make coronavirus treatments or vaccines.
Apr 24, 2020 - Glaxo's (GSK) Vaccines and Respiratory segments are likely to have driven sales in the first quarter. Results will provide clarity on the impact of coronavirus on the company's business.
Apr 22, 2020 - ASM International NV (OTCQX:ASMIY) Q1 2020 Results Conference Call April 22, 2020 09:00 AM ET Company Participants Victor Bareño - Director of Investor Relations Chuck del Prado - Chief Executive Offi
Apr 22, 2020 - The following slide deck was published by ASM International NV in conjunction with their 2020 Q1 earnings call.
Apr 22, 2020 - Akzo Nobel NV (OTCQX:AKZOF) Q1 2020 Earnings Conference Call April 22, 2020, 03:00 ET Company Participants Lloyd Midwinter - Director of Communications & Investor Relation Thierry Vanlancker - Cha
Apr 22, 2020 - Targeted therapies for treating sickle cell disease are finally here after a 60-year wait.
Apr 22, 2020 - Solid sales of Roche's (RHHBY) new drugs in the first quarter more than offset the competition from biosimilars.
Apr 21, 2020 - Investor focus is likely to be on the impact of the coronavirus outbreak on Lilly's (LLY) performance when it reports first-quarter results.
Apr 21, 2020 - Novartis (NVS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Apr 21, 2020 - Alexion (ALXN) gains as it announces plans to initiate a study to evaluate Ultomiris for the COVID-19 infection.